Notably, in addition to the loss of the tumor-suppressive function of wild-type (WT) p53, many mutant p53 proteins acquire new oncogenic activities to promote cancer progression, called gain of function (GOF) [13,14,15]. The gene discussed is TP53; the disease is cancer.